N-of-1 Hub were very responsive and engaged, working with us to determine the optimal protocol using the N-of-1 design. We worked together to develop the N-of-1 protocol, which we were very excited about because it allowed us to perform a thorough, sham-controlled study without requiring a large patient population. We had a very positive experience with N-of-1 Hub. They were at all times responsive, engaged, and very thorough. We are currently evaluating additional studies in various conditions, and always look for ways to use the N-of-1 protocol design due to its ease of implementation and suitability for individualised treatments like personalized rTMS, especially if the condition is found in limited patient population sizes.
Dr Chris Oliver,
N-of-1 Hub was of great assistance in helping us develop our protocols for a migraine trial using a single-case design. They expertly applied knowledge to our clinical situation and were extremely professional and easy to work with. We are a firm believer that single-case designs have a very important role to play in future nutraceutical research. We highly recommend N-of-1 Hub.
Dr Ali Crichton,
N-of-1 Hub has provided mentoring on the use of use of N-of-1 trial methodology in an Australian-first N-of-1 trial of ADHD medication in Fetal Alcohol Spectrum Disorder. N-of-1 Hub's extensive experience in trial design using N-of-1 methodologies, rich understanding of the nuance of N-of-1 trial management, and collaborative, friendly nature has facilitated high quality research and allowed us to easily overcome hurdles as they’ve arisen!